Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 June, 2018 05:54 IST
Zydus Cadila gets USFDA's final nod for Tizanidine tablets
Source: IRIS | 13 Mar, 2018, 11.05AM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the USFDA to market Tizanidine Tablets USP in the strengths of 2 mg and 4 mg.

The drug is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury and works by helping to relax the muscles.

It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

The group now has more than 180 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Shares of the company gained Rs 11.3, or 2.94%, to trade at  Rs 395.10.  The total volume of shares traded  was  24,840 at the BSE (10.47 a.m., Tuesday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Sensex ends 257 points higher; Nifty settles at 10,822-level - 22-Jun-2018 15:58
Atishay bags project for Providing Technical Support Services for Rajasthan UID Project - 22-Jun-2018 12:28
IRIS Business Services appoints CDSL as designated depository - 22-Jun-2018 11:32
DHFL expects 30% growth in home loan disbursements from Karnataka - 22-Jun-2018 11:22
KPIT, Kinetiq announce strategic life sciences collaboration - 22-Jun-2018 11:09
AstraZeneca receives marketing permission for Durvalumab in India - 22-Jun-2018 11:05
JSW Steel to invest USD 500 mn to upgrade Acero Junction plant in USA - 22-Jun-2018 11:01
Capacite Infra led consortium bags Rs 117.44 bn MHADA redevelopment project - 22-Jun-2018 10:56
HCL Technologies partners with Nokia for digital transformation - 22-Jun-2018 10:24
Sensex slips nearly 70 points; Nifty below 10,750-level - 22-Jun-2018 10:18
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer